Found: 15
Select item for more details and to access through your institution.
Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 24, p. 8193, doi. 10.1002/ange.201903112
- By:
- Publication type:
- Article
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00164-4
- By:
- Publication type:
- Article
Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 11, p. 2275, doi. 10.1002/1878-0261.13417
- By:
- Publication type:
- Article
A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00543-8
- By:
- Publication type:
- Article
Discovery of Broad‐Spectrum Repurposed Drug Combinations Against Carbapenem‐Resistant Enterobacteriaceae (CRE) Through Artificial Intelligence (AI)‐Driven Platform.
- Published in:
- Advanced Therapeutics, 2024, v. 7, n. 3, p. 1, doi. 10.1002/adtp.202300332
- By:
- Publication type:
- Article
Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 7, p. 1, doi. 10.1002/adtp.202000034
- By:
- Publication type:
- Article
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.
- Published in:
- Bioengineering & Translational Medicine, 2023, v. 8, n. 1, p. 1, doi. 10.1002/btm2.10363
- By:
- Publication type:
- Article
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development.
- Published in:
- Bioengineering & Translational Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1002/btm2.10196
- By:
- Publication type:
- Article
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 453, p. 1, doi. 10.1126/scitranslmed.aan0941
- By:
- Publication type:
- Article
Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity.
- Published in:
- Angewandte Chemie International Edition, 2019, v. 58, n. 24, p. 8109, doi. 10.1002/anie.201903112
- By:
- Publication type:
- Article
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens.
- Published in:
- NPJ Digital Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s41746-022-00627-4
- By:
- Publication type:
- Article
Addressing antimicrobial resistance with the IDentif.AI platform: Rapidly optimizing clinically actionable combination therapy regimens against nontuberculous mycobacteria.
- Published in:
- Theranostics, 2022, v. 12, n. 16, p. 6848, doi. 10.7150/thno.73078
- By:
- Publication type:
- Article
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02436-9
- By:
- Publication type:
- Article
Photodynamic Therapy: A Flexi‐PEGDA Upconversion Implant for Wireless Brain Photodynamic Therapy (Adv. Mater. 29/2020).
- Published in:
- Advanced Materials, 2020, v. 32, n. 29, p. 1, doi. 10.1002/adma.202070219
- By:
- Publication type:
- Article
A Flexi‐PEGDA Upconversion Implant for Wireless Brain Photodynamic Therapy.
- Published in:
- Advanced Materials, 2020, v. 32, n. 29, p. 1, doi. 10.1002/adma.202001459
- By:
- Publication type:
- Article